Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials

Background: The reciprocal nexus between sleep and pain is well-documented, with the deleterious impact of operative trauma potentially playing a pivotal role in the dysregulation of this interplay, which could significantly contribute to the manifestation of postoperative delirium (POD). Studies ha...

Full description

Bibliographic Details
Main Authors: Wenjie Xu, Yuxiang Zheng, Qing Wang, Zizheng Suo, Lingling Fang, Jing Yang, Shuai Li, Peng Li, Xixi Jia, Xiaoyan Liu, Hui Zheng, Cheng Ni
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Heliyon
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2405844024036545
_version_ 1827293987892887552
author Wenjie Xu
Yuxiang Zheng
Qing Wang
Zizheng Suo
Lingling Fang
Jing Yang
Shuai Li
Peng Li
Xixi Jia
Xiaoyan Liu
Hui Zheng
Cheng Ni
author_facet Wenjie Xu
Yuxiang Zheng
Qing Wang
Zizheng Suo
Lingling Fang
Jing Yang
Shuai Li
Peng Li
Xixi Jia
Xiaoyan Liu
Hui Zheng
Cheng Ni
author_sort Wenjie Xu
collection DOAJ
description Background: The reciprocal nexus between sleep and pain is well-documented, with the deleterious impact of operative trauma potentially playing a pivotal role in the dysregulation of this interplay, which could significantly contribute to the manifestation of postoperative delirium (POD). Studies have investigated the effect of adding dexmedetomidine (DEX) to patient-controlled intravenous analgesia (PCIA) pumps on postoperative pain-sleep interaction cycle and POD, but conclusions remained uncertain. The objective of this investigation is to perform a meta-analysis that thoroughly assesses the impact of integrating DEX into PCIA, focusing on analgesic effectiveness, sleep quality, and the incidence of delirium in postoperative patients. Methods: PubMed, Embase, Cochrane Library, SinoMed, and Wanfang Data Knowledge Service Platform were searched, for publications in any language, from database inception to September 2023. Our analysis encompassed randomized controlled trials (RCTs) that examine the therapeutic efficacy and risk profile of adding DEX to the PCIA on the postoperative pain-sleep interaction cycle, by focusing on changes in postoperative analgesia (Visual analog scale (VAS) score), sleep efficiency, sleep structure, subjective sleep score (Assen insomnia scale and numerical rating scale) and adverse event rate. Results: 34 RCTs (4324 patients) were analyzed. This study shows DEX improved analgesia and reduced VAS scores at 6, 12, and 24 h after surgery. Sleep efficiency was enhanced on the 1st and 2nd postoperative night. DEX improved sleep structure at the 1st postoperative night by reducing non-rapid eye movement stage 1 (N1) sleep and increasing non-rapid eye movement stage 2 (N2) and non-rapid eye movement stage 3 (N3) sleep. At the 2nd night, DEX reduced N1 sleep and increased N2 sleep, but not N3 sleep. Data from AIS and NRS showed improvement in subjective sleep scores on the 1st postoperative night and 2nd night. Additionally, DEX decreased the occurrence of POD on the 24 h and first-three days. Conclusion: This study shows that the typical DEX doses added to PCIA with sufentanil were 2–5 μg/kg or approximately 200–250 μg, and the addition of DEX to PCIA can improve pain-sleep interaction cycle from multiple perspectives, and further decrease the occurrence of POD.
first_indexed 2024-04-24T13:49:23Z
format Article
id doaj.art-76fc3a01143a4fbc9ecbd96ffcf849ef
institution Directory Open Access Journal
issn 2405-8440
language English
last_indexed 2024-04-24T13:49:23Z
publishDate 2024-03-01
publisher Elsevier
record_format Article
series Heliyon
spelling doaj.art-76fc3a01143a4fbc9ecbd96ffcf849ef2024-04-04T05:05:18ZengElsevierHeliyon2405-84402024-03-01106e27623Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trialsWenjie Xu0Yuxiang Zheng1Qing Wang2Zizheng Suo3Lingling Fang4Jing Yang5Shuai Li6Peng Li7Xixi Jia8Xiaoyan Liu9Hui Zheng10Cheng Ni11Department of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, Peking University Third Hospital, Beijing 100191, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, ChinaDepartment of Anesthesiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China; Corresponding author.Background: The reciprocal nexus between sleep and pain is well-documented, with the deleterious impact of operative trauma potentially playing a pivotal role in the dysregulation of this interplay, which could significantly contribute to the manifestation of postoperative delirium (POD). Studies have investigated the effect of adding dexmedetomidine (DEX) to patient-controlled intravenous analgesia (PCIA) pumps on postoperative pain-sleep interaction cycle and POD, but conclusions remained uncertain. The objective of this investigation is to perform a meta-analysis that thoroughly assesses the impact of integrating DEX into PCIA, focusing on analgesic effectiveness, sleep quality, and the incidence of delirium in postoperative patients. Methods: PubMed, Embase, Cochrane Library, SinoMed, and Wanfang Data Knowledge Service Platform were searched, for publications in any language, from database inception to September 2023. Our analysis encompassed randomized controlled trials (RCTs) that examine the therapeutic efficacy and risk profile of adding DEX to the PCIA on the postoperative pain-sleep interaction cycle, by focusing on changes in postoperative analgesia (Visual analog scale (VAS) score), sleep efficiency, sleep structure, subjective sleep score (Assen insomnia scale and numerical rating scale) and adverse event rate. Results: 34 RCTs (4324 patients) were analyzed. This study shows DEX improved analgesia and reduced VAS scores at 6, 12, and 24 h after surgery. Sleep efficiency was enhanced on the 1st and 2nd postoperative night. DEX improved sleep structure at the 1st postoperative night by reducing non-rapid eye movement stage 1 (N1) sleep and increasing non-rapid eye movement stage 2 (N2) and non-rapid eye movement stage 3 (N3) sleep. At the 2nd night, DEX reduced N1 sleep and increased N2 sleep, but not N3 sleep. Data from AIS and NRS showed improvement in subjective sleep scores on the 1st postoperative night and 2nd night. Additionally, DEX decreased the occurrence of POD on the 24 h and first-three days. Conclusion: This study shows that the typical DEX doses added to PCIA with sufentanil were 2–5 μg/kg or approximately 200–250 μg, and the addition of DEX to PCIA can improve pain-sleep interaction cycle from multiple perspectives, and further decrease the occurrence of POD.http://www.sciencedirect.com/science/article/pii/S2405844024036545DexmedetomidinePatient-controlled intravenous analgesiaSleep disturbancePain-sleep interaction cyclePostoperative delirium
spellingShingle Wenjie Xu
Yuxiang Zheng
Qing Wang
Zizheng Suo
Lingling Fang
Jing Yang
Shuai Li
Peng Li
Xixi Jia
Xiaoyan Liu
Hui Zheng
Cheng Ni
Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials
Heliyon
Dexmedetomidine
Patient-controlled intravenous analgesia
Sleep disturbance
Pain-sleep interaction cycle
Postoperative delirium
title Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials
title_full Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials
title_fullStr Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials
title_full_unstemmed Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials
title_short Impact of the addition of dexmedetomidine to patient-controlled intravenous analgesia on postoperative pain-sleep interaction cycle and delirium: A systematic review and meta-analysis of randomized controlled trials
title_sort impact of the addition of dexmedetomidine to patient controlled intravenous analgesia on postoperative pain sleep interaction cycle and delirium a systematic review and meta analysis of randomized controlled trials
topic Dexmedetomidine
Patient-controlled intravenous analgesia
Sleep disturbance
Pain-sleep interaction cycle
Postoperative delirium
url http://www.sciencedirect.com/science/article/pii/S2405844024036545
work_keys_str_mv AT wenjiexu impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT yuxiangzheng impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT qingwang impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT zizhengsuo impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT linglingfang impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT jingyang impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT shuaili impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT pengli impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT xixijia impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT xiaoyanliu impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT huizheng impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials
AT chengni impactoftheadditionofdexmedetomidinetopatientcontrolledintravenousanalgesiaonpostoperativepainsleepinteractioncycleanddeliriumasystematicreviewandmetaanalysisofrandomizedcontrolledtrials